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Abstract
Adriamycin (ADR) treatment causes an imbalance in the levels of nitric oxide (NNO) and superoxide (O2
N2) production leading
to cardiac injury. Previously we demonstrated that mice lacking inducible nitric oxide synthase (iNOS) have increased
oxidative stress and mitochondrial injury. The molecular events leading to increased mitochondrial injury in iNOS deficient
mice is unknown. ADR in the absence of iNOS preferentially activates a proapoptotic pathway without a concurrent increase
in prosurvival pathways. Treatment with ADR leads to an increase in DNA binding activity of nuclear factor kappa B (NFkB)
and p53 in wildtype mice. Following ADR treatment, p53, but not NFkB DNA binding activity, as well as the level of Bax, a
p53 target gene, was increased in iNOS (2/2) mice. This apoptotic signaling effect in iNOS (2/2) is alleviated by
overexpression of manganese superoxide dismutase (MnSOD). Increases in NFkB and p53 in ADR-treated wildtype mice did
not lead to increases in target genes such as MnSOD, bcl-xL, or Bax. Moreover, co-immunoprecipitation analysis revealed
that p65, a prominent member of the NFkB family, interacts with p53 in the nucleus. These results suggest that NFkB and
p53 may counter act one another’s actions in ADR-treated wildtype (WT) mice. Further, these results identify a novel
mechanism by which oxidative stress may regulate transcription of proapoptotic genes.
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Introduction
Adriamycin (ADR) remains one of the most widely used
chemotherapeutic agents, although there is a known dose-
dependent cardiac toxicity. The cardiac injury associated with
the use of ADR is hypothesized to be related to subsequent
increases in superoxide (O2
N2) production. The quinone contain-
ing anthracycline participates in a one electron reduction reaction
in which molecular oxygen accepts an electron, thus producing
O2
N2. Redox cycling of ADR occurs through both enzymatic and
non-enzymatic reactions. Enzymes such as cytochrome P-450
reductase, NADH dehydrogenase, xanthine oxidase, as well as
non-enzymatic reduction catalyzed by iron, have been shown to
participate in the redox cycling of ADR and the formation of O2
N2
[1].
Adriamycin-induced cardiac toxicity has been proposed to be a
consequence of mitochondrial injury [2]. Ultrastructural analysis
of heart tissue following treatment with ADR reveals mitochon-
drial swelling, loss of cristae, and vacuolization. Previously, we
have demonstrated that overexpression of manganese superoxide
dismutase (MnSOD) is protective against ADR-induced cardiac
injury using a transgenic mouse model [2–4]. This result suggests
that O2
N2 production as a result of ADR treatment most likely
occurs in the mitochondria. Additionally, inducers of MnSOD
protein and activity such as phenylbutyrate, a histone deacetylase
inhibitor, are also cardioprotective in ADR-induced toxicity [5].
The role of nitric oxide (NNO) in ADR-induced cardiac injury is
not well established. Inducible nitric oxide synthase (iNOS) null
mice exhibited an exacerbation of injury in response to ADR
treatment as compared to wildtype (WT) mice identified by
ultrastructural analysis, biochemical markers such as serum
creatine phosphokinase (CPK), lactate dehydrogenase (LDH),
and cardiac troponin (cTnI) [6]. In addition, levels of serum
nitrate and nitrotyrosine adducted proteins increased in WT mice
following ADR treatment, but were absent in iNOS (2/2) mice
[2–4]. Although these results provide insight leading to potential
explanations for the exacerbation of injury in iNOS null mice, the
mechanism is not clear.
In the present study, we utilize an acute model of ADR toxicity
to further elucidate the possible mechanism(s) by which ROS and
NNO may serve as signal mediators regulating expression of anti-
and apoptotic target genes. We demonstrate that activation of
NFkB and p53 transcription factors interact to offset the
expression of cytoprotective (MnSOD and bcl-xL) and proapop-
totic (Bax) genes.
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Materials and Methods
Generation of mice
Inducible NOS knock-out mice were purchased from Jackson
Laboratories (Bar Harbor, ME) in the C57BL/6 background. The
iNOS (2/2) mice were bred into the B6C3 background for
greater than 10 generations and the colony was maintained at the
University of Kentucky. Three lines of MnSOD over-expressing
mice were generated in the B6C3 background using human
MnSOD cDNA [2]. The human b-actin 59 flanking sequence and
promoter was used to target mRNA expression predominantly in
the heart tissue [2]. The medium expressing line (TgM (+/2)) was
bred to obtain homozygous MnSOD overexpression (TgM (+/+)).
The iNOS (2/2) - TgM (+/+) cross was generated by sequential
selection and back-crossing between iNOS (2/2) and TgM (+/+)
mice [6]. Homozygosity was confirmed by back-crossing to WT
mice. After more than 10 generations of back-crossing, male mice,
8–10 weeks old were used for experiments. Age- and gender-
matched WT mice were bred and maintained in the B6C3
background to serve as controls. Procedures that involved mice
were approved by the University of Kentucky Animal Care and
Use Committee and were conducted in accordance to all policies
for the use and care of laboratory research animals as set-forth by
the NIH.
Southern blot analysis
Genomic DNA was isolated from mouse tail as previously
described [7]. The DNA was digested overnight at 37uC with
BamH I or Pst I, and separated on 0.7% or 0.9% agarose. The gel
was denatured and neutralized prior to transferring overnight to a
Nytran membrane (Schleicher & Schuell, Keene, NH). Using a
vacuum oven pre-warmed to 80uC, the blot was baked for 2 h.
Prior to hybridization with probe, the blot was prehybridized for
5 h at 42uC in hybridization buffer (5X SSPE, 50% formamide,
5X Denhardt’s solution, 0.1% SDS, and 0.1 mg/ml denatured
salmon sperm DNA). Using 32P labeled iNOS or hMnSOD
cDNA, the membrane was hybridized at 42uC for 48 h. Using a
buffer containing 5X SSC, 0.1% SDS, and 0.05% sodium
pyrophosphate, the blot was washed for 15 min at room
temperature twice. The last washing step was performed at
65uC in 0.1X SSC, 0.1% SDS, and 0.05% sodium pyrophosphate.
The blot was then exposed to Kodak x-ray film at 280uC
overnight.
Animal treatment and tissue isolation
Male mice between the ages of 8–10 wks received one
intraperitoneal (i.p.) injection at a dosage of 20 mg/kg ADRIA-
MYCIN PFSH (Pharmacia & Upjohn, Kalamazoo, MI) while
control mice received saline solution. At various time points, mice
were anesthetized using NembutalH sodium solution (65 mg/kg)
(Abbott Laboratories, North Chicago, IL). Blood was removed
from the left ventricle by cardiac puncture using a 1-ml syringe
with a 25G5/8 needle. Blood was transferred to a MicrotainerH
Brand Serum Separator Tube (Becton Dickinson and Company,
Franklin Lakes, NJ) and allowed to clot for 2 h at room
temperature. The serum was obtained by centrifugation at
60006g at room temperature for 5 min. Serum was analyzed
immediately upon isolation. The heart tissue was homogenized by
polytron in 0.05 M potassium phosphate buffer, pH 7.8, sonicated
on ice for three 15 s bursts using 10% output, and frozen for
enzymatic assay of SOD.
Enzymatic SOD activity assay
Protein concentration of homogenate was determined using a
colorimetric assay (BioRad Laboratories, Hercules, CA). The
SOD activity of each sample was determined by the NBT method
as described previously [8]. In order to assay the activity of
MnSOD, NaCN (561023) was added to the mixture to inhibit
copper, zinc superoxide dismutase (CuZnSOD) activity. Enzyme
activities (Units/mg protein) are from 6 animals of each genotype.
Western blot analysis
Protein concentration of homogenate was determined using a
colorimetric assay (BioRad Laboratories, Hercules, CA). The
homogenate (20 mg) was electrophoresed using SDS-PAGE
method and transferred to a nitrocellulose or PVDF membrane.
The membrane was washed and then blocked in Blotto [5% milk,
10 mM Tris-HCl, 150 mM NaCl (pH 8.0), and 0.05% Tween 20]
for 1 h at room temperature. An affinity purified rabbit anti-
MnSOD antibody purchased from Upstate or anti-4-hydroxyno-
nenal (4HNE) (Alexis) antibody was used. After two washings in
TBST [10 mM Tris-HCl, 150 mM NaCl (pH 8.0), and 0.05%
Tween 20], the blot was incubated with goat anti-rabbit IgG
conjugated to horseradish peroxidase from Santa Cruz Biotech-
nology (Santa Cruz, CA) at a 1:3000 dilution in Blotto for 1.5 h at
room temperature. The blot was washed three times in TBST and
once with TBS [10 mM Tris-HCl, and 150 mM NaCl (pH 8.0)].
Protein bands were visualized using the ECL detection system
from Amersham Pharmacia Biotech (Buckinghamshire, England).
An affinity purified sheep anti-CuZnSOD antibody (1:3000),
purchased from Calbiochem or anti-glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) antibody (1:3000) (Trevigen) was used
for a loading control.
Table 1.
Gene Annealing Temp., 6C Number of Cycles Primer Sequence
MnSOD 55 40 59-GCTTGATAGCCTCCAGCAAC-39
39-GGCCAAGGGAGATGTTACAA-59
Bcl-xL 58 25 59-CCGACTCACCAATACCTGCATCTC39
39-CCAGAAGAAACTGAAGCAGAGAGGG-59
Bax 59 30 59-AGGATGATTGCTGACGTGGACACG-39
39-AAGATGGTCACTGTCTGCCATGTGG-59
GAPDH 50 20 59-TGAAGGTCGGTGTGAACGGATTTGGC-39
39-CATGTAGGCCATGAGGTCCACCAC-59
doi:10.1371/journal.pone.0089251.t001
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Nitrate measurement
Serum was centrifuged using ULTRAFREEH-0.5 Biomax-30
membrane tubes at 10,0006g for 30 min. A final volume of
200 mL including 40 mL of sample, 40 mL of nitrate/nitrite assay
buffer, and 10 mL each of nitrate reductase co-factor and nitrate
reductase enzyme preparation was incubated, covered at room
temperature for 3 h. After the addition of 50 mL each of Greiss
Reagent R1 and R2, the samples were incubated uncovered for
10 min at room temperature and the formation of a deep purple
azo compound was detected using a spectrophotometer at
Figure 1. Transgenic mice overexpressing MnSOD have increased enzyme activity and protein expression. (a) Superoxide dismutase
activity of heart tissue homogenate in four genotypes: WT, iNOS (2/2), TgM (++), and iNOS (2/2)-TgM (++). Data are expressed as mean6 SEM. *p,
0.05 for MnSOD compared to WT and iNOS (2/2). (b) Protein extracts were analyzed by Western blot using an antibody detecting MnSOD. Protein
extracts were co-hybridized with an antibody detecting CuZnSOD to assess equal loading of the samples.
doi:10.1371/journal.pone.0089251.g001
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540 nm. All reagents were obtained from Cayman Chemical (Ann
Arbor, MI).
Electrophoretic mobility shift assay
Heart tissue was excised and nuclear extracts were isolated as
previously described, with the inclusion of 35% glycerol and
protease inhibitors (pepstatin, aprotinin, leupeptin) at 1 mg/mL in
the extraction buffer [9]. Protein concentration was determined by
a colorimetric assay (BioRad Laboratories, USA). Oligonucleo-
tides corresponding to NFkB or p53 were purchased from Santa
Cruz as follows, NFk B: 59-AGTTGAGGGGACTTTCC-
CAGGC-39 and p53: 59-TACAGAACATGTCTAAGCATGC-
TGGGG-39. Each oligonucleotide was radioactively end labeled
with [c-32P] ATP (3000 Ci/mmol at 10 mCi/mL) and T4
polynucleotide kinase (New England Biolabs, Beverly, MA). The
probes were purified on a 20% native page gel. The gel was
exposed to Kodak film and the band corresponding to the double
strand was excised. The DNA was eluted overnight at 37uC in
300 mL of Tris/HCl, 1 mM EDTA buffer (pH 7.4). The activity
of the labeled probe was counted and stored at 280uC. The final
volume of each reaction was 20 mL and included 12 mg of nuclear
extract protein. In each reaction, 4 mL of 5-fold binding buffer
[20% glycerol, 5 mM MgCl2, 2.5 mM EDTA, 5 mM DTT,
50 mM Tris/HCl, pH 7.5, 0.25 mg/mL poly (deoxyinosinic-
deoxycytidylic acid)] and 40,000 cpm of labeled probe were used.
Samples were incubated at room temperature for 20 min. The
reaction was stopped by addition of 10X DNA loading buffer
[25 mM Tris-HCl (pH 7.5), 0.02% bromophenol blue, and 4%
glycerol]. DNA-protein complexes were separated from unbound
probe on a native 6% PAGE gel in 0.5X Tris-borate-EDTA
buffer. Gels were vacuum dried and exposed to Kodak film at 2
80uC.
Real time PCR
Total tissue RNA, 3 h following treatment with ADR, was
isolated with Trizol (1 heart/1 mL) and further purified using the
RNeasy Mini, RNA isolation kit (Qiagen). Total RNA was eluted
from the RNeasy Mini columns with 60 mL of RNase-free water.
Total RNA was reverse transcribed (1 mg) using an RT kit
(Clontech Laboratories). Complimentary DNA was obtained using
oligo(dT) primers (Clontech Laboratories) and was stored at 2
80uC. Primers purchased from Invitrogen and used for quantita-
tive real time PCR are listed in the Table 1. The LightCycler
Instrument using LightCycler-DNA Master SYBR Green I
(Roche) was used with LightCycler 3.5.3 software to analyze
results. Final concentrations in each reaction were 2 mg cDNA,
3 mM MgCl2, 5 pmol of sense, 5 pmol of antisense, and
1XSYBER Green mix (DNA double-strand specific dye). Stan-
dard curves using 0.5, 1, 2, 4, 5, and 6 mg of cDNA were used to
quantitate PCR products. Normalization was two-fold, using same
amounts of cDNA for each reaction, as well as, analyzation of a
housekeeping gene, GAPDH. Samples were analyzed in triplicates
using N=3 for each murine genotype and treatment.
Immunoprecipitation
Immunoprecipitation studies with nuclear extracts from heart
homogenate were performed in RIPA buffer [9.1 mM Na2HPO4/
1.7 mM NAH2PO4/150 mM NaCl (pH 7.4)/1% (v/v) Nonidet
P40/0.5% sodium deoxycholate/0.1% SDS/10 mg/mL PMSF/
1 mg/mL aprotinin]. Rabbit IgG TruBlot (eBioscience) was used
with a rabbit anti-p65 antibody (Santa Cruz) and a monoclonal
mouse anti-p53 (Oncogene). Pre-cleared nuclear extract was
incubated with anti-p65 overnight at 4uC. Anti-Rabbit IgG beads
were added and incubated for 2 h at room temperature. After
centrifugation, beads were washed 4X with RIPA buffer (100 mL).
Samples were resuspended in sample loading buffer, subjected to
SDS/PAGE [12.5% (w/v) gel] and then transferred to nitrocel-
lulose. After transfer samples were analyzed by Western blotting.
Statistical analysis
Multiple comparisons for each variable were performed using
analysis of variance (ANOVA) with the post hoc Fisher’s test.
When applicable, the unpaired t-test was used to test the
significance of each pre-planned comparison. Data was considered
statistically significant for P#0.05. All data is presented as mean 6
SEM.
Results
Manganese superoxide dismutase activity and protein
expression is increased in TgM (+/+) and iNOS (2/2)
-TgM (+/+) mice
Superoxide dismutase enzyme activity was assayed in all four
murine models using the method previously described by Oberley
et al. [8]. Figure 1A shows that levels of MnSOD and CuZnSOD
enzyme activity are similar in WT and iNOS (2/2) mice. Mice
overexpressing MnSOD have a two-fold increase in enzyme
activity with no concurrent change in CuZnSOD activity
Figure 2. Serum nitrate is significantly increased in WT but not iNOS (2/2), TgM (+/+), or iNOS (2/2)-TgM (+/+) mice following
treatment with ADR. Serum nitrate concentration (mM) following time course treatment with ADR (n = 6–8 mice for each time point) was
determined. Values are expressed as mean 6 SEM. *p,0.0001 versus saline for WT mice.
doi:10.1371/journal.pone.0089251.g002
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Figure 3. Oxidative injury marker, 4-hydroxynonenal (4-HNE) significantly increases at an earlier time point in iNOS (2/2) mice
than WT mice following treatment with ADR. Protein extracts isolated from (a) WT, (b) iNOS (2/2), (c) TgM (++), and (d) iNOS (2/2)-TgM (++)
mice were analyzed by Western blot using a 4-HNE antibody after ADR treatment (n = 3 mice for time points 1,3 and 6 h). Membranes were co-
hybridized with an antibody detecting GAPDH to assure equal loading of the samples and are quantitated for (e) WT (wildtype), (f) iNOS (2/2), (g)
TgM (++), and (h) iNOS (2/2)-TgM (++) mice. *p,0.05 versus saline within each genotype.
doi:10.1371/journal.pone.0089251.g003
ADR-Induced Interaction of p53 and p65
PLOS ONE | www.plosone.org 5 February 2014 | Volume 9 | Issue 2 | e89251
[Figure 1A, p,0.05 compared to WT and iNOS (2/2)].
Figure 1B demonstrates that overexpression of MnSOD in TgM
(+/+) and iNOS (2/2)-TgM (+/+) mice correlates with an
increase in enzymatically active protein levels, consistent with
activation of enzyme activity (Figure 1A). Copper-zinc SOD
protein expression is unchanged.
Serum nitrate is significantly increased in WT mice
In order to probe the role of NNO in the mechanism of ADR-
induced cardiac injury, serum nitrate concentration was deter-
mined following ADR treatment in all four mouse models. Serum
nitrate levels increase early following ADR treatment in WT mice
and are significantly higher 24 h after ADR treatment (Figure 2,
p,0.0001, compared to iNOS (2/2), TgM (+/+) and iNOS
(2/2)-TgM (+/+) mice). Previous studies have demonstrated that
levels of nitrate in serum are significantly higher in WT mice
compared to controls as early as 6 h following ADR treatment [6].
Mice overexpressing MnSOD had similar levels of serum nitrate
as WT mice; however, there was no increase in serum nitrate after
ADR treatment at 24 h (Figure 2). Basal levels of serum nitrate in
both iNOS (2/2) and iNOS (2/2)-TgM (+/+) were lower than
WT and TgM (+/+), consistent with the lack of iNOS in both
models (Figure 2). There is no statistical difference in serum nitrate
in iNOS (2/2) and iNOS (2/2)-TgM (+/+) following treatment
with ADR.
Oxidative injury marker, 4-HNE is elevated at an earlier
time point in iNOS (2/2) than WT mice
We previously reported that mitochondrial oxidative damage
precedes nitrative damage in ADR-induced cardiotoxicity, as
assessed my electron microscopy [10]. Using Western blot analysis
and whole lane densitometry (normalized to GAPDH), Figures 3A
and 3E show that WT mice have increased 4-HNE-adducted
protein expression beginning at 3 h and statistically significant
Figure 4. p53 DNA binding activity is significantly increased in WT and mice lacking iNOS. Nuclear extract (12 mg) from heart tissue was
isolated, pooled (N= 4–6 animals per lane) from (a) WT and iNOS (2/2), (b) TgM (++), and (c) iNOS (2/2)-TgM (++) mice, and assayed for p53 DNA
binding activity. Specificity of DNA binding activity was determined using an anti-p53 antibody, as well as competition with unlabeled p53
oligonucleotide. Densitometric quantitation as fold increase from respective saline control using both individual animals and pooled samples is
shown in (d). *p,0.025 versus saline for WT and iNOS (2/2) mice.
doi:10.1371/journal.pone.0089251.g004
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Figure 5. Bax mRNA expression is significantly increased in iNOS (2/2) mice following treatment with ADR. Real time PCR was used to
evaluate Bax mRNA expression (6 h) following ADR treatment in WT, iNOS (2/2), TgM (++), and iNOS (2/2)-TgM (++) mice. Data are expressed as
fold increase from respective saline control. *p,0.025 versus saline for iNOS (2/2) mice.
doi:10.1371/journal.pone.0089251.g005
Figure 6. NFkB DNA binding activity is increased in WTmice. Nuclear extract (12 mg) from heart tissue of WT, iNOS (2/2), TgM (++), and iNOS
(2/2)-TgM (++) mice was isolated and assayed for NFkB DNA binding activity. Densitometric quantitation as fold increase from respective saline
control is shown (with gel shift inset). *p,0.001 versus saline for WT.
doi:10.1371/journal.pone.0089251.g006
ADR-Induced Interaction of p53 and p65
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increases 6 h following ADR treatment (p,0.05). Mice that lack
iNOS demonstrated an earlier increase in 4-HNE, at 1 h following
ADR treatment, which continued to increase up to 6 h (Figures 3B
and 3F; p,0.05). Importantly, Figures 3C, 3D, 3G, and 3H show
that both TgM (+/+) and iNOS (2/2)-TgM (+/+) mice have
significantly less 4-HNE adducted proteins, respectively, after
ADR treatment. The earlier increase in this oxidative parameter
implies that iNOS (2/2) mice have an earlier onset of oxidative
injury in response to ADR compared to WT mice, which is
attenuated by overexpression of MnSOD.
DNA binding activity of p53 is significantly increased in
WT and iNOS (2/2) mice
The redox-sensitive transcription factor, p53, is known to
regulate pro-apoptotic gene products in response to oxidative
injury [11–13]. Changes in the DNA binding activity of p53 were
Figure 7. MnSOD and bcl-xL mRNA expression are not changed following treatment with ADR. Real time PCR was used to evaluate (a)
MnSOD and (b) Bcl-xL mRNA levels (6 h) following ADR treatment in WT, iNOS (2/2), TgM (++), and iNOS (2/2)-TgM (++) mice.
doi:10.1371/journal.pone.0089251.g007
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assessed in all four murine models. Figure 4a shows that WT and
iNOS (2/2) mice have significant increases (p,0.025) in p53
DNA binding activity 3 h after ADR treatment. However, iNOS
(2/2) mice demonstrated slightly higher basal levels of p53 DNA
binding activity than that of WT mice. Transgenic mice treated
with ADR have a small, but not significant increase in p53 DNA
binding activity as compared to saline controls (Figure 4B).
Inducible NOS null mice which overexpress MnSOD, also have a
slight, but non-significant increase in p53 DNA binding activity as
shown in Figure 4C. Figure 4D illustrates the quantitative increase
in p53 DNA binding activity of all four murine models.
Bax, a target gene of p53 is significantly increased in
iNOS (2/2) mice
The transcription factor p53 is sensitive to oxidative injury and
responsible for transcription of the proapoptotic gene, Bax [14–
18]. The mRNA levels of Bax were assessed in ADR-treated
animals. Figure 5 shows that iNOS (2/2) mice had a significant
(p,0.025) increase in Bax mRNA after ADR treatment. There
were no significant differences in Bax mRNA in response to ADR
amongst the three remaining murine models (Figure 5).
NFkB DNA binding activity is significantly increased in
WT mice
To elucidate potential cytoprotective signaling pathways up-
regulated in ADR-induced cardiac injury, the DNA binding
activity of redox-sensitive transcription factor, NFkB, was deter-
mined by EMSA as demonstrated for p53. Wild type animals
treated with ADR had a significant increase (p,0.001) in NFkB
DNA binding activity at 3 h compared to saline controls (Figure 6).
However, mice lacking iNOS demonstrated no significant
difference from saline controls 3 h after ADR. Transgenic mice
overexpressing MnSOD and mice null for iNOS (2/2)-TgM
(+/+) had no change in NFkB response to ADR.
NFkB target genes, MnSOD and Bcl-xL, do not change
following ADR treatment
NFkB is responsible for the transcription of the antioxidant,
MnSOD, and anti-apoptotic gene, Bcl-xL [19–22]. The mRNA
levels of MnSOD and Bcl-xL were assessed by quantitative real
time PCR. Figure 7A shows that there were no significant
differences in MnSOD mRNA amongst the four murine models in
response to ADR. The mRNA levels of Bcl-xL did not change
among the four murine models (Figure 7B).
p53 interacts with p65 in the nucleus after treatment
with ADR
In order to determine the role of elevated redox sensitive
transcription factors NFkB and p53 in WT mice, we co-
immunoprecipitated p65, a prominent member of the NFkB
family with an anti-p53 antibody. Using Western blot analysis,
Figure 8a demonstrates that p65 protein expression is increased
following ADR treatment in WT mice. Importantly, Figure 8b
confirms the presence of p65 and the interaction with p53 in the
nuclear fraction following ADR treatment.
Discussion
Adriamycin is a broad spectrum anthracycline antibiotic used
for treatment of most solid tumors; however, its clinical usefulness
is limited by the potential lethal cardiac injury. The mechanisms
by which ADR exerts its anti-tumor effects may differ from the
mechanisms resulting in cardiac toxicity [23,24]. While the
significance of ADR-induced production of reactive oxygen
species (ROS) in the killing of cancer cells may not be
predominately focused on in the literature, the role and concern
of ADR-induced ROS in cardiac toxicity is well documented [24].
Advances have been made to further understand the underlying
mechanisms associated with both the acute and chronic toxicity of
ADR, however cell signaling events, as well as subcellular targets
involved are not well understood. Previous studies have demon-
strated that ADR affects cardiac specific gene regulation as early as
2 h following administration [25]. The present study focuses on
early cell signaling events that precede ADR-induced cardiomy-
opathy and demonstrates that ADR-induced cardiac injury in
wildtype mice leads to co-incidental activation of both cytopro-
tective and toxic signaling pathways resulting in an interaction of
members of the NFkB family with p53. These results underscore
the significance of NNO production in the control of cardiac injury.
Using ultrastructural analysis, we have previously shown that
ADR has toxic effects on the heart consisting of mitochondrial
degradation, loss of cristae, and vacuolization [3,4,6]. Addition-
ally, the lack of iNOS in ADR-induced cardiac injury leads to an
exacerbation of damage related to an absence of NNO production
[3,6]. Distinctively, iNOS null mice exhibit greater mitochondrial
damage over the total area of heart tissue [3]. The increase in
mitochondrial injury resulting from the lack of iNOS can be
alleviated by overexpression of MnSOD [3,4,6]. In contrast,
Pacher et al. demonstrated that ADR-induced slight improvements
in the cardiac function of iNOS (2/2) mice [26]. Variations in
measurements of cardiac function exist between ex vivo and in
vivo methods and both methods have known limitations.
Limitations can include, but aren’t limited to, systemic and/or
neurohumoral modulation such as CNS and blood volume, which
are variables extrinsic of the heart. Importantly, cardiac function
measurements ex vivo provide an indication of cardiac status
independent of other systolic factors. One other important
difference is the background strain of the mice, which can
contribute to measured differences between the study performed
by Pacher et al. and the observations reported herein. The mice
used in this study and the previously published results are bred
more than 10th generation in B6C3 background compared to
C57BL/6 [6]. Measurements of cardiac function are in agreement
Figure 8. Induction and interaction of p65 with p53 in nuclear
extract following treatment with ADR. Expression of p65 increases
following treatment with ADR (A). Immunoprecipitation with p65
demonstrating an interaction with p53 in the nucleus after treatment
with ADR. Anti-p65 was used to reprobe membrane to verify presence
of p65 (B).
doi:10.1371/journal.pone.0089251.g008
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with the ultrastructural pathology and biochemical data in the
same genetic backgrounds and therefore the observed effects of
iNOS is documented here.
Formation of 4-hydroxynonenal (4-HNE) adducts can serve as
second messenger signal mediators and/or markers of oxidative
tissue damage [27,28]. In an effort to link the production of ROS
and RNS production to the exacerbation of injury shown in iNOS
(2/2) mice, a time course study was used to analyze for serum
nitrate production and 4-HNE protein adducts. Previous reports
demonstrate immunohistochemical staining of iNOS and 3-
nitrotyrosine following ADR treatment in mice [3,29]. These
results support that iNOS is increased in response to ADR
treatment. Additionally, the serum nitrate levels were increased as
early as 6 h in WT mice after ADR treatment followed by an
increase in nitrotyrosine protein adducts [6]. To extend previous
studies, Figure 2 demonstrates that serum nitrates increase up to
24 h following ADR treatment, but only in WT mice. Mice which
overexpress MnSOD have basal nitrate levels similar to WT mice,
however do not have elevated nitrate levels in response to ADR.
Mice lacking iNOS which overexpress MnSOD, have both lower
basal levels of serum nitrate and demonstrate no change following
ADR treatment. In agreement with our findings, previous studies
showed that ADR treatment leads to increases in nitrate levels in
heart tissue and serum isolated from rat [11,30]. Mice lacking
iNOS have increased 4-HNE adducts beginning at 1 h following
ADR treatment (Figure 3). This increase is statistically significant
and earlier than that seen in WT mice at 3 h. These results
indicate that levels of oxidative injury due to ADR are higher for
iNOS (2/2) mice as compared to WT, and iNOS null mice
lacked the ability to increase significant NNO production. In
addition, previous studies using immunogold analysis revealed that
iNOS (2/2) mice have increased 4-HNE adducts relative to 3-
nitrotyrosine levels as compared to WT mice [3,10]. Overexpres-
sion of MnSOD in both transgenic and iNOS (2/2)-TgM (++)
mice demonstrate little to no change in 4-HNE levels after
treatment with ADR. The attenuation of 4-HNE protein adduct
expression in MnSOD overexpressing mice further verifies that
O2
N2 mediates ADR-induced tissue damage.
Previous studies have suggested that formation of peroxynitrite
occurs following ADR administration [31]. Serum nitrite levels
increase in WT mice following ADR treatment (Figure 2) and
previous findings demonstrated increases in nitrotyrosine protein
adducts [10]. Since it is known that the simultaneous production of
NNO and O2
N2 can lead to peroxynitrite formation [32], the data
presented in this study further support the findings reported by
Mukhopadhyay et al [31]. Peroxynitrite is a potent oxidizing and
nitrating species that can give rise to deleterious effects, but can
also lead to fatty acid nitration, resulting in formation of adaptive
anti-inflammatory mediators in cardiac mitochondria [33,34]. It is
also well known that NNO can easily diffuse into the lipid bilayer,
blocking the propagation of lipid peroxyl radicals [35]. Since NNO
can react with ADR-derived O2
N2, as well as lipid peroxyl radicals
and overexpression of MnSOD attenuates cardiac injury in iNOS
deficient mice [6], it is possible that mice lacking iNOS may have
excess oxidative stress following ADR treatment.
Transcription factor p53 has been shown to be involved in
redox-sensitive signaling under conditions of oxidative stress
[13,14,18]. Much of the literature has focused on p53 and its
relevance to the guardian of the genome [14,18,36,37]. Levels of
p53 are known to increase following oxidative challenging
conditions causing cellular stress such as UV radiation, hypoxia,
heat shock, and cytotoxic drug treatments [12,13]. Importantly,
transcription activity of p53 has been associated with regulation of
apoptotic genes in the mitochondria such as Bax, p21, AIF, Fas/
APO1, and Noxa [23]. Here we report that the DNA binding
activity of p53 is significantly increased in WT and iNOS (2/2)
mice 3 h following treatment with ADR (Figure 4A). Increased
levels of p53 in WT and iNOS (2/2) mice correlates with the
presence of 4-HNE protein adducts as compared to the lack of a
change in p53 levels following ADR in mice overexpressing
MnSOD.
The redox sensitive transcription factor, NFkB, is increased only
in WT mice 3 h following ADR treatment as compared to saline
controls (Figure 6). The increase in NFkB DNA binding activity is
correlated with the early increases in serum nitrate production
found in WT mice, but absent in iNOS (2/2) mice, indicating
that NNO or nitrosative stress may mediate a cell signaling response
to ADR treatment. However, mice lacking iNOS had no change
in NFkB binding activity after ADR treatment. This data in
combination with 4-HNE analysis also suggests that ADR-induced
oxidative injury, as opposed to nitrosative stress, mediates the
signaling response in mice lacking iNOS. This result is consistent
with the findings reported by Zingarelli et al. showing that the
absence of iNOS enhances myocardial damage in ischemia
reperfusion injury (IRI) [38]. Specifically Zingarelli et al. showed
that the binding activity of NFkB and AP-1 were significantly
reduced in mice lacking iNOS as compared to controls, indicating
that iNOS was responsible for a beneficial role in IRI [38].
Transgenic mice and iNOS (2/2) mice overexpressing MnSOD
show no change in the binding activity of NFkB after ADR
treatment. Manna et al. reported a similar result whereby MCF27
cells overexpressing MnSOD and stimulated with tumor necrosis
factor (TNF), a known inducer of NFkB, had no change in NFkB
DNA binding activity [39]. Additionally, transgenic mice lacking
iNOS, but overexpressing MnSOD had no significant changes in
serum nitrate production, or nitrosative stress response to ADR
treatment. Downstream gene products regulated by NFkB
signaling were unchanged in WT mice (Figure 7). Although, p53
DNA binding activity was increased in WT and mice lacking
iNOS, Bax was only increased in iNOS deficient mice. Impor-
tantly, p53 was co-immunoprecipitated with p65 in nuclear
extracts following treatment with ADR. This data suggests that
p53 and NFkB counteract each other in WT mice. This finding
suggests that NFkB negatively regulates p53.
These results overall suggest that NNO mediates a cellular
response to ADR treatment in WT mice eliciting an increase in
binding activity of NFkB. The DNA binding activity of p53
significantly increases in WT and mice lacking iNOS. Additional
studies report that p53 represses SOD2 expression at the promoter
level [40]. This result could possibly explain why there is no
change in the mRNA expression of MnSOD in WT mice after
ADR treatment.
In summary, 1) transgenic and mice lacking iNOS, but
overexpressing MnSOD do not have significant increases in p53
binding activity, perhaps due in part to reduced levels of ROS
mediated apoptosis signaling leading to the observed protection
when challenged with ADR treatment, 2) mice which lack iNOS
are unable to produce a high level of NNO production and
therefore have an absence of enhanced NFkB binding activity
suggesting a role for NNO in NFkB activation, 3) WT mice have
increased NFkB and p53 DNA binding activity, but there is no
change in downstream gene products, suggesting that interaction
of p53 with NFkB inactivates p53 transcription activity, which is
further supported by the fact that iNOS (2/2) mice are unable to
activate NFkB, but exhibit increased Bax mRNA, a known p53
target gene. Overall, these studies indicate that NNO production,
thereby regulating NFkB and p53 pathways, is protective in
ADR-induced cardiac tissue signaling. Therapeutic interventions
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limiting the production of NNO may be clinically detrimental,
especially where ADR chemotherapy is involved. Moreover, these
results support recent findings where oral delivery of inorganic
nitrates is suggested for patients receiving ADR [41]. Further
studies are required to demonstrate overall protection provided by
NNO/nitrate in ADR-induced cardiac toxicity.
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